Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.
Published October 7, 2020 · Recall initiated: September 4, 2020
Summary
FDA records drug Class II recall D-0003-2021, published October 7, 2020 and initiated September 4, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 32,543 cartons; Lot: Lot # 190017, exp. 02/2021; 190161, exp. 08/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Below specification result for buprenorphine release rate.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPRENORPHINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPRENORPHINE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide in the U.S. and PR
- Lot
- Lot # 190017, exp. 02/2021; 190161, exp. 08/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDABuprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDCJune 14, 2023
- FDARIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL 16 oz. For Oral UseOctober 7, 2020
- FDANicotine Gum, Nicotine Polacrilex Gum USP, 2 mg (nicotine), 110-count pieces per carton, Distributed By: RiteOctober 7, 2020
- FDAStrides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx OnlyOctober 7, 2020
- FDAblumen ADVANCED INSTANT HAND SANITIZER Clear ETHYL ALCOHOL 70% Natural Boost with Tea Tree Oil, (70% ethylOctober 7, 2020
Questions about this recall
Was Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21. recalled?
Yes. FDA published recall D-0003-2021 on October 7, 2020. Reported hazard: Failed Stability Specifications: Below specification result for buprenorphine release rate.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPRENORPHINE.